Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: A randomized controlled trial

Endoscopy

Volumn 43, Issue 4, 2011, Pages 325-330

  Zolotarevsky, E ^a,d   Fehmi, S M ^a,b   Anderson, M A ^a   Schoenfeld, P S ^a   Elmunzer, B J ^a   Kwon, R S ^a   Piraka, C R ^a   Wamsteker, E J ^a   Scheiman, J M ^a   Korsnes, S J ^a   Normolle, D P ^a,c   Kim, H Myra ^a   Elta, G H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UCSD MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 FRENCH STENT; 5 FRENCH STENT; ADULT; ARTICLE; FEMALE; GUIDE WIRE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS DUCT; PANCREATITIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT;

ADULT; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC DUCTS; PANCREATITIS; RISK FACTORS; STENTS;

EID: 79953207743     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0030-1256305     Document Type: Article

References (20)

1. Cotton P B., Lehman G, Vennes J et al,. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991 37 383-393
2. Fazel A, Quadri A, Catalano M F. et al,. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003 57 291-294 (Pubitemid 36350781)
3. Singh P, Das A, Isenberg G et al,. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004 60 544-550 (Pubitemid 39311536)
4. Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001 54 209-213
5. Smithline A, Silverman W, Rogers D et al,. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993 39 652-657 (Pubitemid 23282518)
6. Tarnasky P R., Palesch Y Y., Cunningham J T. et al,. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998 115 1518-1524 (Pubitemid 28546003)
7. Das A, Singh P, Sivak Jr. M V., Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007 65 960-968 (Pubitemid 46783815)
8. Smith M T., Sherman S, Ikenberry S O. et al,. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996 44 268-275 (Pubitemid 26318327)
9. Rashdan A, Fogel E L., McHenry Jr. L et al,. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004 2 322-329 (Pubitemid 38447197)
10. Chahal P, Tarnasky P R., Petersen B T. et al,. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2009 7 834-839
11. Freeman M L., Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004 59 8-14 (Pubitemid 38095500)
12. Komorita S S. Attitude content, intensity, and the neutral point on a Likert scale. J Soc Psychol 1963 61 327-334
13. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932 140 1-55
14. Mallery J S., Baron T H., Dominitz J A. et al,. Complications of ERCP. Gastrointest Endosc 2003 57 633-638
15. Cotton P B. LG, Vennes J, Geenen J E. et al,. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991 37 383-393
16. Spiegelhalter D J., Freedman L S., Blackburn P R. Monitoring clinical trials: conditional or predictive power? Control Clin Trials 1986 7 8-17 (Pubitemid 16166393)
17. Masci E, Mariani A, Curioni S, Testoni P A. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003 35 830-834 (Pubitemid 37254216)
18. Aronson N, Flamm C R., Bohn R L. et al,. Evidence-based assessment: patient, procedure, or operator factors associated with ERCP complications. Gastrointest Endosc 2002 56 (Suppl. 6) S294-S302 (Pubitemid 36236860)
19. Harewood G C., Pochron N L., Gostout C J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005 62 367-370 (Pubitemid 41187937)
20. Derfus G A. GJ, Hogan W J. Effects of endoscopic pancreatic duct stent placement on pancreatic ductal morphology [abstract]. Gastrointest Endosc 1990 36 (206A)